Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (HKG:1349)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
2.820
+0.030 (1.06%)
Apr 21, 2026, 4:08 PM HKT

HKG:1349 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
1,1471,0561,1961,2891,209
Short-Term Investments
---30-
Cash & Short-Term Investments
1,1471,0561,1961,3191,209
Cash Growth
8.60%-11.67%-9.35%9.13%-13.46%
Accounts Receivable
297.75469.96620.49679.12672.49
Other Receivables
0.311.080.165.141.18
Receivables
298.07471.04620.64684.26673.66
Inventory
33.2147.2743.6540.5335.63
Other Current Assets
7.1632.189.2425.19.77
Total Current Assets
1,4861,6071,8692,0691,928
Property, Plant & Equipment
477.25503.53475.33351.51301.92
Long-Term Investments
229.07257.49287.53306.37327.86
Other Intangible Assets
60.8768.6586.3562.3288.46
Long-Term Deferred Tax Assets
131.41133.28100.8785.979.22
Long-Term Deferred Charges
4.419.28-43.0936.12
Other Long-Term Assets
2.127.557.1857.6219.64
Total Assets
2,3912,5872,8772,9762,781
Accounts Payable
6.0710.678.057.438.17
Accrued Expenses
171.35167.5736.8634.6753.78
Short-Term Debt
---101-
Current Portion of Leases
5.356.16.338.228.68
Current Income Taxes Payable
--1.611.6310.4
Current Unearned Revenue
5.418.340.260.31348.87
Other Current Liabilities
57.4558.27451.9520.0998.3
Total Current Liabilities
245.62250.95505.02673.34528.2
Long-Term Leases
9.3414.4310.9515.622.59
Long-Term Unearned Revenue
18.9715.852.1534.0440.8
Total Liabilities
273.93281.23518.12722.99591.58
Common Stock
103.66103.66103.66102.9104.3
Additional Paid-In Capital
1,2901,2901,2891,2251,265
Retained Earnings
728.37916.9970.46934.39868.43
Treasury Stock
-----40.82
Comprehensive Income & Other
-6.05-5.55-5.86-5.2-4.05
Total Common Equity
2,1162,3052,3582,2572,193
Minority Interest
0.430.711.01-4.08-3.36
Shareholders' Equity
2,1172,3052,3592,2532,190
Total Liabilities & Equity
2,3912,5872,8772,9762,781
Total Debt
14.6920.5317.28124.8131.26
Net Cash (Debt)
1,1321,0361,1791,1941,178
Net Cash Growth
9.33%-12.12%-1.33%1.43%-14.49%
Net Cash Per Share
1.091.001.141.161.13
Filing Date Shares Outstanding
1,0371,0371,0371,0291,032
Total Common Shares Outstanding
1,0371,0371,0371,0291,032
Working Capital
1,2401,3561,3641,3961,400
Book Value Per Share
2.042.222.272.192.12
Tangible Book Value
2,0552,2362,2712,1952,104
Tangible Book Value Per Share
1.982.162.192.132.04
Buildings
396.73368.53199.22198.52198.52
Machinery
500.03504.91388.63341.74322.86
Construction In Progress
0.197.2229.96122.3748.9
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.